Halozyme Therapeutics
HALO
#2173
Rank
โ‚ฌ6.80 B
Marketcap
53,52ย โ‚ฌ
Share price
0.16%
Change (1 day)
68.97%
Change (1 year)

Market capitalization of Halozyme Therapeutics (HALO)

Market cap: โ‚ฌ6.80 Billion

As of January 2025 Halozyme Therapeutics has a market cap of โ‚ฌ6.80 Billion. This makes Halozyme Therapeutics the world's 2173th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Halozyme Therapeutics from 2004 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ6.80 B15.71%
2024โ‚ฌ5.88 B33.24%
2023โ‚ฌ4.41 B-38.42%
2022โ‚ฌ7.17 B43.48%
2021โ‚ฌ4.99 B6.49%
2020โ‚ฌ4.69 B116.94%
2019โ‚ฌ2.16 B16.91%
2018โ‚ฌ1.85 B-23%
2017โ‚ฌ2.40 B97.63%
2016โ‚ฌ1.21 B-40.12%
2015โ‚ฌ2.03 B103.62%
2014โ‚ฌ0.99 B-19.76%
2013โ‚ฌ1.24 B117.44%
2012โ‚ฌ0.57 B-24.71%
2011โ‚ฌ0.75 B26.79%
2010โ‚ฌ0.59 B59.44%
2009โ‚ฌ0.37 B15.14%
2008โ‚ฌ0.32 B-14%
2007โ‚ฌ0.37 B-9.54%
2006โ‚ฌ0.41 B353.05%
2005โ‚ฌ92.56 M16%
2004โ‚ฌ79.79 M

End of Day market cap according to different sources

On Jan 27th, 2025 the market cap of Halozyme Therapeutics was reported to be:

โ‚ฌ6.80 Billion
by Nasdaq info icon info icon
โ‚ฌ6.80 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ1.60 B-76.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ696.34 B 10,126.68%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ16.36 B 140.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ145.83 B 2,041.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ128.12 B 1,781.73%๐Ÿ‡ซ๐Ÿ‡ท France
โ‚ฌ352.67 B 5,079.49%๐Ÿ‡บ๐Ÿ‡ธ USA